Total Funding
87
60
Total FundingConvertible Note raised
Growth Score 87 in past quarter
3 pts
Heat Score 60 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
64765
SciTech Development is a specialty pharmaceutical company focusing on cancer treatments.
- Earle Holsapple: President & CEOPast Role: Sterling Pacific, Founder and Managing Director
- Louis Scarmoutzos: Chief Operations Officer
About the Company
SciTech Development is a specialty pharmaceutical company focusing on cancer treatments. It has developed a Drug Delivery Platform (SDP) that enables scientists to engineer, develop, and patent new drugs. Its first, patented drug candidate, ST-001-nanoFenretinide combines SDP and the promising drug fenretinide as a broadly applicable anticancer
drug.